JNJ-64300535

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-64300535, covering 2025-05-26 to 2025-05-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus Infection [Phase 1]

See pricing